Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Invariant Natural Killer T Cells from Donor Lymphocyte Infusions (DLI-iNKTs) Contribute to Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplantation

Simona Jahnke, Hannes Schmid, MSc, Kathy-Ann Secker, MSc, Silke Duerr-Stoerzer, Hildegard Keppeler, Rebecca Baur, Michael Schumm, Dr. MD vet., Rupert Handgretinger, MD PhD, Wolfgang Bethge, MD, Lothar Kanz, Corina Schneidawind, MD, Dominik Schneidawind, MD

Blood (2018) 132 (Supplement 1): 3340.

https://doi.org/10.1182/blood-2018-99-111745

Published: 2018

Journal Articles

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

Blood (2018) 132 (Supplement 1): 604.

https://doi.org/10.1182/blood-2018-99-110124

Published: 2018

Journal Articles

First Results of a Prospective Multicenter Phase I/II Clinical Trial in Adult Patients Using Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning

Wolfgang Bethge, MD, Stephan Mielke, MD, Dietger Niederwieser, MD, Roland Meisel, MD, Donald w. Bunjes, MD, Arne Brecht, MD, Jurgen Kuball, MD, Sandra Karitzky, PhD, Silke Holtkamp, Christiane Siewert, PhD, Stefanie Pflitsch, Michael Schumm, DVM, Matthias K. Eyrich, MD, Vladan Vucinic, Markus Wiesneth, MD, Kasper Westinga, Rupert Handgretinger, MD PhD

Blood (2017) 130 (Supplement 1): 213.

https://doi.org/10.1182/blood.V130.Suppl_1.213.213

Published: 2017

Journal Articles

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD PhD, Sandra Karitzky, PhD, Silke Holtkamp, Christiane Siewert, PhD, Stefanie Pflitsch, Michael Schumm, DVM, Matthias K. Eyrich, MD, Markus Wiesneth, MD, Halvard Bonig, MD MA, Rupert Handgretinger, MD PhD

Blood (2017) 130 (Supplement 1): 214.

https://doi.org/10.1182/blood.V130.Suppl_1.214.214

Published: 2017

Journal Articles

Addition of Plerixafor Overcomes Poor Mobilization in Autologous and Allogeneic Stem Cell Grafts and Leads to Efficient and Sustained Engraftment

Sebastian Haen, MD, Irmtraud Schober-Melms, Michael Schumm, DVM, Joerg Henes, Robert Möhle, MD, Wolfgang Bethge, MD, Lothar Kanz, Wichard Vogel

Blood (2017) 130 (Supplement 1): 5457.

https://doi.org/10.1182/blood.V130.Suppl_1.5457.5457

Published: 2017

Journal Articles

Effects of Various ATG Doses on Rejection Rate and Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Peter J. Lang, MD, Friedhelm Schuster, Bernd Gruhn, Roland Meisel, MD, Patrick Schlegel, MD, Anne-Marie Lang, Chihab Klose, Wolfgang Schwinger, MD, Tobias F. Feuchtinger, Prof. Dr. MD, Heiko-Manuel Teltschik, Holger Martinius, Michael Schumm, DVM, Rupert Handgretinger, MD

Blood (2017) 130 (Supplement 1): 3250.

https://doi.org/10.1182/blood.V130.Suppl_1.3250.3250

Published: 2017

Journal Articles

TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial

Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD, Sandra Karitzky, PhD, Silke Holtkamp, PhD, Christiane Siewert, PhD, Michael Schumm, VMD, Matthias K. Eyrich, MD, Markus Wiesneth, Halvard Bönig, MD, Rupert Handgretinger, MD

Blood (2016) 128 (22): 389.

https://doi.org/10.1182/blood.V128.22.389.389

Published: 2016

Journal Articles

Decentralized Manufacture of TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Grafts for Children within a Multicenter Phase I/II Clinical Trial

Michael Schumm, VMD, Matthias K. Eyrich, MD, Markus Wiesneth, Halvard Bönig, MD, Peter J. Lang, MD, Paul G. Schlegel, MD, Roland Meisel, MD, Ansgar S. Schulz, MD, Johann Greil, MD, Peter Bader, MD, Murat Aktas, Philipp Dresing, PhD, Sandra Karitzky, PhD, Silke Holtkamp, PhD, Rupert Handgretinger, MD

Blood (2016) 128 (22): 2172.

https://doi.org/10.1182/blood.V128.22.2172.2172

Published: 2016

Journal Articles

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Wolfgang Schwinger, MD, Patrick Schlegel, MD, Michael Schumm, DVM, Anne-Marie Lang, Barbara Lang, MD, Carl Philipp Schwarze, MD, Martin Ebinger, MD, Christian E. Urban, MD, Rupert Handgretinger

Blood (2014) 124 (21): 852.

https://doi.org/10.1182/blood.V124.21.852.852

Published: 2014

Journal Articles

Haploidentical TCRab Depleted Hematopoietic Cell Transplantation Leads To Rapid Immune Reconstitution and Promising Clinical Outcome In Adults

Sebastian P. Haen, MD, Michael Schumm, DVM, Wichard Vogel, MD, Christoph Faul, MD, Rupert Handgretinger, Lothar Kanz, MD, Wolfgang A. Bethge, MD

Blood (2013) 122 (21): 5475.

https://doi.org/10.1182/blood.V122.21.5475.5475

Published: 2013

Journal Articles

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Michael Schumm, DVM, Patrick Schlegel, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Carl-Philipp Schwarze, MD, Rupert Handgretinger

Blood (2013) 122 (21): 692.

https://doi.org/10.1182/blood.V122.21.692.692

Published: 2013

Journal Articles

A New Dosing Scheme of ATG-F Prevents Rejection and Maintains Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Peter Lang, MD, Tobias F. Feuchtinger, MD, Patrick Schlegel, MD, Heiko-Manuel Teltschik, MD, Roland Meisel, MD, Friedhelm R. Schuster, MD, Bernd Gruhn, MD, Wolfgang Schwinger, MD, Christian E. Urban, MD, Holger Martinius, Ulrike Pflückhahn, Rouwen Teltschik, Christina Kyzirakos, Michael Schumm, DVM, Rupert Handgretinger, MD

Blood (2012) 120 (21): 4154.

https://doi.org/10.1182/blood.V120.21.4154.4154

Published: 2012

Journal Articles

Flow Cytometry Based Chimerism Analysis Can Predict Graft Rejection in Pediatric Patients Receiving HLA Mismatched Stem Cell Transplantation

Heiko-Manuel Teltschik, MD, Hanna Kreil, Patrick Schlegel, MD, Tobias F. Feuchtinger, MD, Michael Schumm, DVM, Rupert Handgretinger, MD, Peter Lang, MD

Blood (2012) 120 (21): 4156.

https://doi.org/10.1182/blood.V120.21.4156.4156

Published: 2012

Journal Articles

CD34 Selected Stem Cells Boosts Are Safe and Effective for Patients with Poor Bone Marrow Function After Allogeneic Hematopoietic Cell Transplantation.

Sebastian P. Haen, Michael Schumm, DVM, Christoph Faul, MD, Lothar Kanz, MD, Wolfgang A. Bethge, MD, Wichard Vogel, MD

Blood (2012) 120 (21): 3078.

https://doi.org/10.1182/blood.V120.21.3078.3078

Published: 2012

Journal Articles

Transplantation of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors: Robust Engraftment and Rapid Immune Reconstitution In Children with High Risk Leukemia

Rupert Handgretinger, MD, Peter Lang, MD, Tobias F. Feuchtinger, MD, Michael Schumm, DVM, Heiko-Manuel Teltschik, MD, Ansgar S Schulz, MD, PhD, Volker Huppert, PhD, Lorenzo Moretta, MD, Alesandro Moretta, MD, Maria Ester Bernardo, MD, Maurizio Caniglia, MD, Alice Bertaina, MD, Francesco Zinno, MD, Franco Locatelli, MD

Blood (2011) 118 (21): 1005.

https://doi.org/10.1182/blood.V118.21.1005.1005

Published: 2011

Journal Articles

Use of IL15 Stimulated, CD3/19 Depleted Transplants From Haploidentical Donors In Pediatric Malignancies

Peter Lang, Matthias Pfeiffer, Heiko-Manuel Teltschik, Tobias F. Feuchtinger, MD, Martin Ebinger, Ingo Mueller, Michael Schumm, Rupert Handgretinger, MD, PhD

Blood (2010) 116 (21): 3548.

https://doi.org/10.1182/blood.V116.21.3548.3548

Published: 2010

Journal Articles

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

Tobias Feuchtinger, Kathrin Opherk, Wolfgang A. Bethge, Max S. Topp, Friedhelm R. Schuster, Eva M. Weissinger, Mohamad Mohty, Reuven Or, Michael Maschan, Michael Schumm, Klaus Hamprecht, Rupert Handgretinger, Peter Lang, Hermann Einsele

Blood (2010) 116 (20): 4360–4367.

https://doi.org/10.1182/blood-2010-01-262089

Published: 2010

Journal Articles

Long Term Survival and Relapse Rate After Transplantation of Highly T and B Cell Depleted Stem Cells From Alternative Donors in Pediatric Patients with Acute Lymphatic Leukemia.

Peter J. Lang, MD, Ingo Mueller, Heiko-Manuel Teltschik, Michael Schumm, Matthias Pfeiffer, Tobias Feuchtinger, Johann Greil, Peter Bader, Thomas Klingebiel, MD, Rupert Handgretinger, MD

Blood (2009) 114 (22): 4333.

https://doi.org/10.1182/blood.V114.22.4333.4333

Published: 2009

Journal Articles

Improved T Cell Recovery After Transplantation of CD3/CD19 depleted Haploidentical Stem Cell Grafts in Pediatric Patients.

Heiko-Manuel Teltschik, Tobias Feuchtinger, Matthias Pfeiffer, Michael Schumm, Ingo Mueller, Rupert Handgretinger, Peter J. Lang, MD

Blood (2009) 114 (22): 4652.

https://doi.org/10.1182/blood.V114.22.4652.4652

Published: 2009

Journal Articles

Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation

Peter J. Lang, MD, Matthias Pfeiffer, MD, Heiko-Manuel Teltschik, MD, Ingo Mueller, MD, Tobias Feuchtinger, MD, Michael Schumm, MD, Rupert Handgretinger, MD

Blood (2008) 112 (11): 2907.

https://doi.org/10.1182/blood.V112.11.2907.2907

Published: 2008

NARROW

Invariant Natural Killer T Cells from Donor Lymphocyte Infusions (DLI-iNKTs) Contribute to Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplantation

Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning

First Results of a Prospective Multicenter Phase I/II Clinical Trial in Adult Patients Using Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning

Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial

Addition of Plerixafor Overcomes Poor Mobilization in Autologous and Allogeneic Stem Cell Grafts and Leads to Efficient and Sustained Engraftment

Effects of Various ATG Doses on Rejection Rate and Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial

Decentralized Manufacture of TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Grafts for Children within a Multicenter Phase I/II Clinical Trial

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Haploidentical TCRab Depleted Hematopoietic Cell Transplantation Leads To Rapid Immune Reconstitution and Promising Clinical Outcome In Adults

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

A New Dosing Scheme of ATG-F Prevents Rejection and Maintains Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation

Flow Cytometry Based Chimerism Analysis Can Predict Graft Rejection in Pediatric Patients Receiving HLA Mismatched Stem Cell Transplantation

CD34 Selected Stem Cells Boosts Are Safe and Effective for Patients with Poor Bone Marrow Function After Allogeneic Hematopoietic Cell Transplantation.

Transplantation of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors: Robust Engraftment and Rapid Immune Reconstitution In Children with High Risk Leukemia

Use of IL15 Stimulated, CD3/19 Depleted Transplants From Haploidentical Donors In Pediatric Malignancies

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

Long Term Survival and Relapse Rate After Transplantation of Highly T and B Cell Depleted Stem Cells From Alternative Donors in Pediatric Patients with Acute Lymphatic Leukemia.

Improved T Cell Recovery After Transplantation of CD3/CD19 depleted Haploidentical Stem Cell Grafts in Pediatric Patients.

Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only